Implications for Nurses
The authors encouraged the use of closed systems as a means of decreasing exposure and limiting risk of experiencing adverse events.
In addition, the advent of the use of novel agents, such as targeted therapies and immunotherapies, was considered in the treatment of patients with cancer and how these agents could affect health.
“There is an increase in the use of new therapies such as targeted therapies, immunotherapies, and monoclonal antibodies where the hazard of exposure of these agents to healthcare workers has not yet been identified. Therefore closed systems should be used to prevent exposure until there is documented evidence that these agents do not pose a health risk to people who work with them,” concluded the authors.
Simons A, Toland S. Perceived adverse effects from handling systemic anti-cancer therapy agents. Br J Nurs. 2017;26(16):S38-S44.